A phase III study of voclosporin in Japanese and non-Japanese patients.

Trial Profile

A phase III study of voclosporin in Japanese and non-Japanese patients.

Planning
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Voclosporin (Primary)
  • Indications Lupus nephritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2017 According to an Aurinia Pharmaceuticals Media Release, data from Ethnic Bridging Study (see profile 271230) supports use of the 23.7mg BID voclosporin dose in this trial.
    • 09 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top